Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP588185.RAAwiC3J-t2Taf7sHHweGCvtok4TtpMCknu5NH_X-sKag130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP588185.RAAwiC3J-t2Taf7sHHweGCvtok4TtpMCknu5NH_X-sKag130_assertion type Assertion NP588185.RAAwiC3J-t2Taf7sHHweGCvtok4TtpMCknu5NH_X-sKag130_head.
- NP588185.RAAwiC3J-t2Taf7sHHweGCvtok4TtpMCknu5NH_X-sKag130_assertion description "[We investigated genetically affected leukemic cells in FIP1L1-PDGFRA+ chronic eosinophilic leukemia (CEL) and in BCR-ABL1+ chronic myeloid leukemia (CML), two myeloproliferative disorders responsive to imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588185.RAAwiC3J-t2Taf7sHHweGCvtok4TtpMCknu5NH_X-sKag130_provenance.
- NP588185.RAAwiC3J-t2Taf7sHHweGCvtok4TtpMCknu5NH_X-sKag130_assertion evidence source_evidence_literature NP588185.RAAwiC3J-t2Taf7sHHweGCvtok4TtpMCknu5NH_X-sKag130_provenance.
- NP588185.RAAwiC3J-t2Taf7sHHweGCvtok4TtpMCknu5NH_X-sKag130_assertion SIO_000772 17215855 NP588185.RAAwiC3J-t2Taf7sHHweGCvtok4TtpMCknu5NH_X-sKag130_provenance.
- NP588185.RAAwiC3J-t2Taf7sHHweGCvtok4TtpMCknu5NH_X-sKag130_assertion wasDerivedFrom befree-2016 NP588185.RAAwiC3J-t2Taf7sHHweGCvtok4TtpMCknu5NH_X-sKag130_provenance.
- NP588185.RAAwiC3J-t2Taf7sHHweGCvtok4TtpMCknu5NH_X-sKag130_assertion wasGeneratedBy ECO_0000203 NP588185.RAAwiC3J-t2Taf7sHHweGCvtok4TtpMCknu5NH_X-sKag130_provenance.